ArticleOncotarget2017

Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.

William D Gwynne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.